soul study semaglutide Oral and Cardiovascular Outcomes in High-Risk Type 2 Diabetes Novo Nordisk's Semaglutide lowers MACE

Name: soul study semaglutide Oral and Cardiovascular Outcomes in High-Risk Type 2 Diabetes Novo Nordisk's Semaglutide lowers MACE
Brand: www.cleversources.com
SKU: 36831154005
Price: 29.38 USD
Availability: InStock
Rating: 4.8037 (23 reviews)

SKU: 36831154005

4.8

SEK29.38 SEK59.38

Pay in 4 interest-free payments of $7.34 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Live Spec

Novo Nordisk's Semaglutide lowers MACE risk in SOUL trial Results of SOUL Trial with Oral Semaglutide soul study semaglutide New data from the trial is in! Published in The New England Journal Post hoc analysis of SUSTAIN 6 and PIONEER 6 trials suggests that people with type 2 diabetes at high cardiovascular risk treated with semaglutide experience more stable kidney function compared with placebo Kidney International

Store: www.cleversources.com · Domain: www.cleversources.com

Description

Ask a Question or Book an appointment at medAge in Asheville & Greenville